[Anti-ageing therapies in Alzheimer's disease].

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Revista Española de Geriatría y Gerontología

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.regg.2017.02.007PMID 28549745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury

  2017cited by this paper
• Resveratrol and Alzheimer’s Disease: Mechanistic Insights

  2017cited by this paper
• Sex Hormones and Cognition: Neuroendocrine Influences on Memory and Learning.

  2016cited by this paper
• Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer’s Disease

  2016cited by this paper
• Caloric restriction: beneficial effects on brain aging and Alzheimer’s disease

  2016cited by this paper
• Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model

  2016cited by this paper
• An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

  2016cited by this paper
• Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities

  2016cited by this paper
• Physical activity and exercise attenuate neuroinflammation in neurological diseases.

  2016cited by this paper
• A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.

  2016cited by this paper
• Hydroxytyrosol mildly improve cognitive function independent of APP processing in APP/PS1 mice.

  2016cited by this paper
• Meta-analysis of Telomere Length in Alzheimer's Disease.

  2016cited by this paper
• The Geroscience Hypothesis: Is It Possible to Change the Rate of Aging?

  2016cited by this paper
• Epigenetics and aging

  2016cited by this paper
• Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy

  2016cited by this paper
• Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity

  2016cited by this paper
• Aging and Neurodegeneration: A Tangle of Models and Mechanisms

  2016cited by this paper
• How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.

  2015cited by this paper
• A Mutation in Caenorhabditis elegans NDUF-7 Activates the Mitochondrial Stress Response and Prolongs Lifespan via ROS and CED-4

  2015cited by this paper
• The Traditional Mediterranean Diet: An Ancient Prescription for Health and Longevity

  2015cited by this paper
• Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice.

  2015cited by this paper
• Epigenetic Regulation of Memory by Acetylation and Methylation of Chromatin: Implications in Neurological Disorders, Aging, and Addiction

  2015cited by this paper
• Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease

  2015cited by this paper
• Stem cell aging in adult progeria

  2015cited by this paper
• Stem cells and healthy aging

  2015cited by this paper
• Human neural stem cells alleviate Alzheimer-like pathology in a mouse model

  2015cited by this paper
• Dose-Response of Aerobic Exercise on Cognition: A Community-Based, Pilot Randomized Controlled Trial

  2015cited by this paper
• The search for antiaging interventions: from elixirs to fasting regimens.

  2014cited by this paper
• Mediterranean diet and telomere length in Nurses’ Health Study: population based cohort study

  2014cited by this paper
• Growing knowledge of the mTOR signaling network.

  2014cited by this paper
• Reversal of cognitive decline: A novel therapeutic program

  2014cited by this paper
• Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences

  2014cited by this paper
• Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death

  2014cited by this paper
• Dehydroepiandrosterone (DHEA): Hypes and Hopes

  2014cited by this paper
• Phytoestrogens and their effects.

  2014cited by this paper
• Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Caloric restriction, caloric restriction mimetics, and healthy aging in Okinawa: controversies and clinical implications

  2013cited by this paper
• The hallmarks of aging.

  2013cited by this paper
• Role of oestrogens on oxidative stress and inflammation in ageing

  2013cited by this paper
• Metformin improves healthspan and lifespan in mice

  2013cited by this paper
• Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology

  2013cited by this paper
• The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology

  2013cited by this paper
• Metformin: Do we finally have an anti-aging drug?

  2013cited by this paper
• Estrogens, estrogen receptors, and female cognitive aging: the impact of timing.

  2013cited by this paper
• Early Intervention with an Estrogen Receptor β-Selective Phytoestrogenic Formulation Prolongs Survival, Improves Spatial Recognition Memory, and Slows Progression of Amyloid Pathology in a Female Mouse Model of Alzheimer's Disease

  2013cited by this paper
• Neuropsychological and neurophysiological effects of strengthening exercise for early dementia: A pilot study

  2012cited by this paper
• Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer

  2012cited by this paper
• Metformin in obesity, cancer and aging: addressing controversies

  2012cited by this paper
• Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs

  2012cited by this paper
• Brain Endogenous Estrogen Levels Determine Responses to Estrogen Replacement Therapy via Regulation of BACE1 and NEP in Female Alzheimer’s Transgenic Mice

  2012cited by this paper
• Statin Treatment Increases Lifespan and Improves Cardiac Health in Drosophila by Decreasing Specific Protein Prenylation

  2012cited by this paper
• Aerobic exercise in the elderly: a key to successful aging.

  2012cited by this paper
• Females live longer than males: role of oxidative stress.

  2011cited by this paper
• Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease.

  2011cited by this paper
• Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

  2011cited by this paper
• Exercise to the rescue

  2011cited by this paper
• Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.

  2011cited by this paper
• A longer and healthier life with TOR down-regulation: genetics and drugs.

  2011cited by this paper
• [Non invasive gene therapy in neurological diseases].

  2011cited by this paper
• Protective effect of isoflavones against homocysteine-mediated neuronal degeneration in SH-SY5Y cells

  2010cited by this paper
• A blueprint for developing therapeutic approaches that increase healthspan and delay death.

  2010cited by this paper
• Progeria syndromes and ageing: what is the connection?

  2010cited by this paper
• Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity

  2009cited by this paper
• Adherence to a Mediterranean diet, cognitive decline, and risk of dementia.

  2009cited by this paper
• Unnatural Selection : The Challenges of Engineering Tomorrow's People

  2008cited by this paper
• Fisiopatología de la enfermedad de Alzheimer

  2008cited by this paper
• Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease

  2008cited by this paper
• Pursuing the Longevity Dividend

  2007cited by this paper
• Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.

  2006cited by this paper
• Telomeres and telomerase in Alzheimer's disease: Epiphenomena or a new focus for therapeutic strategy?

  2006cited by this paper
• Therapeutic potential of resveratrol: the in vivo evidence

  2006cited by this paper
• Isoflavonic phytoestrogens--new prebiotics for farm animals: a review on research in China.

  2006cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

  2005cited by this paper
• The future of ageing

  2000cited by this paper
• Estimating Treatment Benefits for the Elderly: The Effect of Competing Risks

  1996cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper

• Functional Therapeutic Strategies Used in Different Stages of Alzheimer’s Disease—A Systematic Review

  2022cites this paper
• The ageing as a therapeutic target for Alzheimer ’ s disease ”

  2017cites this paper
• "Commentary: The ageing as a therapeutic target for Alzheimer's disease"

  2017cites this paper